Turn Therapeutics Inc (TTRX)

$4.23 -0.39 (-8.44%)
Market Cap 136.04M
Revenue (ttm) 0.00
Net Income (ttm) -1.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 31,400
Avg Vol 83,240
Day's Range N/A - N/A
Shares Out 29.45M
Stochastic %K 75%
Beta N/A
Analysts Strong Sell
Price Target $8.00

Company Profile

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its na...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 546 4011
Address:
250 N Westlake Blvd, Westlake Village, United States
joedoe007
joedoe007 Jan. 12 at 10:30 PM
$EVTV They will fade this ticker down hard just like they did after the Sep 12 spike to $4 and the subsequent crash to 47 cents Thats the game wall street plays with us innocent shareholders They rally a stock for no reason to $4 and then just when everyone is bullish and jumping w joy, they crash it to 47 cents they did that kind of pump n dump move even worse to $PTHL and $TTRX
0 · Reply
3luxx
3luxx Jan. 12 at 3:55 PM
$TTRX give me $10 🤑 $HIMS $NVDA $NFLX $META
0 · Reply
DiamondPlayz
DiamondPlayz Jan. 5 at 6:10 PM
Seeing bulls rotate into PAVM now. Starting its massive run - Early positioning is key 💎 Low float tickers have been exploding 300% lately. Just 700k shares outstanding, don't miss PAVM ! $TTRX $DVLT $ULY $MASK.X JH
0 · Reply
Optiion_Freakkz
Optiion_Freakkz Jan. 5 at 1:58 PM
Started my 2026 off with about 6k profit! Thanks so much Zeus. I recommend Following @MomentumZeus - he calls them early. Great trader 🚀 $AFJK $TTRX $BBAI $APLD ++
0 · Reply
cashcow1
cashcow1 Dec. 30 at 8:05 PM
$TTRX adding few hundreds here.
1 · Reply
3luxx
3luxx Dec. 30 at 3:48 AM
$TTRX $6 incoming! $NVDA $MSFT $META $TSLA
0 · Reply
notreload_ai
notreload_ai Dec. 29 at 3:18 PM
D. Boral Capital begins coverage of $TTRX with a Buy rating, citing strong dermatology focus, upcoming clinical data, and long-term growth potential. https://notreload.xyz/d-boral-starts-coverage-on-turn-therapeutics-with-buy-rating-and-8-target/
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 3:40 AM
$TTRX
0 · Reply
gobio
gobio Dec. 16 at 5:32 PM
$TTRX TTRX has a supply agreement with Medline, which is about to IPO. I would think this should be a positive for the stock.
1 · Reply
Daddy044
Daddy044 Nov. 28 at 3:37 PM
$TTRX Strong Buy here. And insiders haven’t sold per S1. If anything Form 4s showed buys.
0 · Reply
Latest News on TTRX
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:05 AM EST - 12 hours ago

Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

Jan 7, 2026, 4:05 PM EST - 5 days ago

Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Nov 13, 2025, 8:00 AM EST - 2 months ago

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.

Nov 11, 2025, 4:05 PM EST - 2 months ago

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.

Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine

Nov 11, 2025, 8:00 AM EST - 2 months ago

Turn Therapeutics' GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

Nov 4, 2025, 5:07 PM EST - 2 months ago

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline

Oct 30, 2025, 7:30 AM EDT - 2 months ago

Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

Oct 22, 2025, 8:00 AM EDT - 2 months ago

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

Oct 20, 2025, 8:22 AM EDT - 3 months ago

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

Turn Therapeutics Appoints Arthur Golden to Board of Directors

Oct 14, 2025, 12:07 PM EDT - 3 months ago

Turn Therapeutics Appoints Arthur Golden to Board of Directors

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

Oct 11, 2025, 1:10 AM EDT - 3 months ago

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

ALH BLLN FFLY LFS POM PXED SONC

Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market

Sep 29, 2025, 10:02 AM EDT - 3 months ago

Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market

joedoe007
joedoe007 Jan. 12 at 10:30 PM
$EVTV They will fade this ticker down hard just like they did after the Sep 12 spike to $4 and the subsequent crash to 47 cents Thats the game wall street plays with us innocent shareholders They rally a stock for no reason to $4 and then just when everyone is bullish and jumping w joy, they crash it to 47 cents they did that kind of pump n dump move even worse to $PTHL and $TTRX
0 · Reply
3luxx
3luxx Jan. 12 at 3:55 PM
$TTRX give me $10 🤑 $HIMS $NVDA $NFLX $META
0 · Reply
DiamondPlayz
DiamondPlayz Jan. 5 at 6:10 PM
Seeing bulls rotate into PAVM now. Starting its massive run - Early positioning is key 💎 Low float tickers have been exploding 300% lately. Just 700k shares outstanding, don't miss PAVM ! $TTRX $DVLT $ULY $MASK.X JH
0 · Reply
Optiion_Freakkz
Optiion_Freakkz Jan. 5 at 1:58 PM
Started my 2026 off with about 6k profit! Thanks so much Zeus. I recommend Following @MomentumZeus - he calls them early. Great trader 🚀 $AFJK $TTRX $BBAI $APLD ++
0 · Reply
cashcow1
cashcow1 Dec. 30 at 8:05 PM
$TTRX adding few hundreds here.
1 · Reply
3luxx
3luxx Dec. 30 at 3:48 AM
$TTRX $6 incoming! $NVDA $MSFT $META $TSLA
0 · Reply
notreload_ai
notreload_ai Dec. 29 at 3:18 PM
D. Boral Capital begins coverage of $TTRX with a Buy rating, citing strong dermatology focus, upcoming clinical data, and long-term growth potential. https://notreload.xyz/d-boral-starts-coverage-on-turn-therapeutics-with-buy-rating-and-8-target/
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 3:40 AM
$TTRX
0 · Reply
gobio
gobio Dec. 16 at 5:32 PM
$TTRX TTRX has a supply agreement with Medline, which is about to IPO. I would think this should be a positive for the stock.
1 · Reply
Daddy044
Daddy044 Nov. 28 at 3:37 PM
$TTRX Strong Buy here. And insiders haven’t sold per S1. If anything Form 4s showed buys.
0 · Reply
joedoe007
joedoe007 Nov. 28 at 11:46 AM
$SMX is this a pump n Dump just like how $TTRX was pumped in the premarket like 2 months ago and then it crashed without end???
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 24 at 4:08 AM
$TTRX Turn Therapeutics earns national recognition as one of the “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment.” Learn how the GX-03 IL-36–targeting technology could disrupt the $20B eczema market ahead of 2026 topline data. https://biotechhealthx.com/biotech-news/turn-therapeutics-ttrx-named-top-innovator-in-atopic-dermatitis-with-gx-03-breakthrough/
0 · Reply
jlsnet22
jlsnet22 Nov. 21 at 11:56 PM
$TTRX Insider buying this week. 19K shares by an officer.
0 · Reply
NIVOLOCO
NIVOLOCO Nov. 21 at 8:13 PM
$TTRX 🔥
0 · Reply
newbulloh2
newbulloh2 Nov. 21 at 4:48 PM
$TTRX after hour news play??
0 · Reply
ExileEclipse
ExileEclipse Nov. 19 at 8:09 PM
$TTRX could be a reversal.
0 · Reply
mrblack515
mrblack515 Nov. 19 at 7:49 PM
$TTRX reversal day and begin 💹💹
0 · Reply
foundghost
foundghost Nov. 19 at 7:26 PM
$TTRX $WSHP
0 · Reply
foundghost
foundghost Nov. 19 at 7:26 PM
$TTRX
0 · Reply
mrblack515
mrblack515 Nov. 19 at 6:31 PM
$TTRX boom!💣💣💣
0 · Reply
con4n28
con4n28 Nov. 19 at 6:02 PM
$TTRX is this the next awesome P/D??
1 · Reply
Recon2023
Recon2023 Nov. 19 at 3:02 PM
$TTRX Going BK?????
0 · Reply